Under NASH-driving conditions, Mll4 heterozygous mutant mice were resistant to liver steatosis, inflammation, and fibrosis, suggesting that MLL4 is a critical factor in the progression of liver disease (Figs. 1 and 2). Here, KMT2D is linked to metabolic dysfunction-associated steatohepatitis.